Unigene to Present at the 10th Annual BIO Investor Forum on October 25, 2011

Show Health and Fitness Publications

Thu, October 27, 2011

[ Thu, Oct 27th 2011 ] - Market Wire

Biogen Idec e Portola Pharmaceuticals hanno annun .. ale per Oral Syk, il programma inibitore specific

[ Thu, Oct 27th 2011 ] - Market Wire

Human Genome Sciences and Xoma Fall Victim to Volatile Nature of Biotech Sector

[ Thu, Oct 27th 2011 ] - Market Wire

PharmaGap Sets Time for in Vivo Tests

[ Thu, Oct 27th 2011 ] - Market Wire

Dynavax Reports Third Quarter 2011 Financial Results

[ Thu, Oct 27th 2011 ] - Market Wire

Dynavax Phase 3 Data in Chronic Kidney Disease De .. rates Superiority of HEPLISAV(TM) vs Engerix-B(R)

[ Thu, Oct 27th 2011 ] - Market Wire

Implant Sciences Explosives Detection Technology Protects Major European Bank

[ Thu, Oct 27th 2011 ] - Market Wire

Incyte Reports Third Quarter 2011 Financial Results and Provides Update on Key Clinical Programs

[ Thu, Oct 27th 2011 ] - Market Wire

Acorda Therapeutics to Host Conference Call to Di .. uarter 2011 Financial Results on November 4, 2011

[ Thu, Oct 27th 2011 ] - Market Wire

ICON Reports Q3 revenue growth of 7% to $241 mill .. f $431 million. (NASDAQ:ICLR) (ISIN:IE0005711209)

[ Thu, Oct 27th 2011 ] - Market Wire

Pfizer Receives European Approval to Extend Use o .. ars and Older for the Prevention of Invasive Pneu

Wed, October 26, 2011

[ Wed, Oct 26th 2011 ] - Market Wire

Universal American Corp. Reports Third Quarter 2011 Results

[ Wed, Oct 26th 2011 ] - Market Wire

Baxter to Present at the Credit Suisse 2011 Healthcare Conference

[ Wed, Oct 26th 2011 ] - Market Wire

Medtronic Starts Landmark Study of Hypertension Treatment

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec oglasza pozytywne podsumowanie wynikw .. 3. badan nad doustnym BG-12 u pacjentw ze stward

[ Wed, Oct 26th 2011 ] - Market Wire

Stellar Biotechnologies &;; Life Diagno .. e Agreement for Stellar Brand KLH ELISA Test Kits

[ Wed, Oct 26th 2011 ] - Market Wire

2011 Third Quarter and Nine-Month Results

[ Wed, Oct 26th 2011 ] - Market Wire

Seattle Genetics Appoints Vice President, Medical .. nces Vice President, Quality Management Promotion

[ Wed, Oct 26th 2011 ] - Market Wire

Abiomed to Release New Protect II Data and Econom .. #59; Over 20 Impella Presentations Included i

[ Wed, Oct 26th 2011 ] - Market Wire

Health Canada Clears Immunovaccine for Ovarian Cancer Vaccine Trials

[ Wed, Oct 26th 2011 ] - Market Wire

Cytori to Webcast Third Quarter Financial Results November 3

[ Wed, Oct 26th 2011 ] - Market Wire

Magellan Health Services Joins with Share Our Strength to End Childhood Hunger in America

[ Wed, Oct 26th 2011 ] - Market Wire

Octapharma Locks-in Binding Forecast to Exceed $2M for ProMetic's Prion Capture Resin for H1 2012

[ Wed, Oct 26th 2011 ] - Market Wire

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

[ Wed, Oct 26th 2011 ] - Market Wire

Covidien Launches Worldas First Non-Absorbable, Uni-Directional Knotless Suture

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec annonce des rsultats trs positifs l'i .. se 3 tudiant BG-12 (dimthylfumarate) administr pa

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec annuncia risultati preliminari positi .. ico di fase III del farmaco orale BG-12 (dimetilf

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec Announces Positive Top-Line Results f .. stigating Oral BG-12 (Dimethyl Fumarate) in Multi

[ Wed, Oct 26th 2011 ] - Market Wire

Biogen Idec meldet positive Topline-Ergebnisse au .. zur Prfung von oral verabreichtem BG-12 (Dimethyl

Tue, October 25, 2011

[ Tue, Oct 25th 2011 ] - Market Wire

West to Host 2011 Third Quarter Conference Call

[ Tue, Oct 25th 2011 ] - Market Wire

CytoSorbents Corporation to Present at the IN3 Medical Device Summit

[ Tue, Oct 25th 2011 ] - Market Wire

USANA Health Sciences Reports Third Quarter 2011 Financial Results

[ Tue, Oct 25th 2011 ] - Market Wire

Micro Imaging Technology Receives a Substantial Exclusive Licensing Proposal From EPIC Corporation

[ Tue, Oct 25th 2011 ] - Market Wire

Daniel Levangie Appointed to Insulet's Board of Directors

[ Tue, Oct 25th 2011 ] - Market Wire

The Law Firm of Levi &;; Korsinsky Noti .. Their Investment in K-V Pharmaceutical Company o

[ Tue, Oct 25th 2011 ] - Market Wire

VistaGen Therapeutics Reports Identification of C .. ts High-Yield Purification of Human Pluripotent S

[ Tue, Oct 25th 2011 ] - Market Wire

Amarantus BioSciences Appoints Dr. Owen Garrick as Strategic Advisor

[ Tue, Oct 25th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. earch on Thoratec Corporation and C.R. Bard, Inc.

[ Tue, Oct 25th 2011 ] - Market Wire

Daxor Announces Filing of Patents for Total Body Albumin Analyzer

[ Tue, Oct 25th 2011 ] - Market Wire

OmniGuide Appoints Scott Flora as President & CEO

[ Tue, Oct 25th 2011 ] - Market Wire

ZYTO Corp Appoints Leading Experts to Scientific Advisory Board

[ Tue, Oct 25th 2011 ] - Market Wire

Implant Sciences Sells Follow-On Order to China's Beijing Subway System

[ Tue, Oct 25th 2011 ] - Market Wire

Gilead e GlobeImmune annunciano un contratto di l .. o sviluppo di vaccini terapeutici per il trattame

[ Tue, Oct 25th 2011 ] - Market Wire

Dr. Reddyas Q2 FY12 Financial Results

[ Tue, Oct 25th 2011 ] - Market Wire

Exelixis Appoints Executive Vice President and Chief Commercial Officer

[ Tue, Oct 25th 2011 ] - Market Wire

DaVita Announces Government Inquiry

Mon, October 24, 2011

[ Mon, Oct 24th 2011 ] - Market Wire

Merck Announces Presentation of Phase III Investi .. ULERA (mometasone furoate and formoterol fumarate

[ Mon, Oct 24th 2011 ] - Market Wire

Blinded Results From Low Dose Cohort of Phase II SHIGATEC Trial Presented at IDSA Annual Meeting

[ Mon, Oct 24th 2011 ] - Market Wire

The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Adolor Corporation

[ Mon, Oct 24th 2011 ] - Market Wire

Harwood Feffer LLP Announces Investigation of HealthSpring Inc.

[ Mon, Oct 24th 2011 ] - Market Wire

Edison Expands Cell Therapy Sector Presence with Launch of Research Coverage on Aastrom

[ Mon, Oct 24th 2011 ] - Market Wire

Diligent Boardbooks Announces Fifth Consecutive R .. r, Boardbooks Now Used by 62 TSX Listed Companies

[ Mon, Oct 24th 2011 ] - Market Wire

Syneron Medical to Report Third Quarter 2011 Financial Results on November 10, 2011

[ Mon, Oct 24th 2011 ] - Market Wire

What's Ahead: Today's Economic Outlook - Equity R .. Ware International Inc and St. Jude Medical, Inc.

[ Mon, Oct 24th 2011 ] - Market Wire

Growing Safety Concerns Weigh on Medical Equipment and Supplies Sector

[ Mon, Oct 24th 2011 ] - Market Wire

NPS Pharmaceuticals Reports Upcoming Presentation .. ege of Gastroenterology Annual Scientific Meeting

[ Mon, Oct 24th 2011 ] - Market Wire

Cigna to Acquire HealthSpring

[ Mon, Oct 24th 2011 ] - Market Wire

PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials

[ Mon, Oct 24th 2011 ] - Market Wire

Research on GlaxoSmithKline plc and Merck &;; Co. Inc. -- Big Pharma Stable for Now

[ Mon, Oct 24th 2011 ] - Market Wire

SecureAlert, Inc. Achieves Milestone of Deploymen .. Units of Its Newest ReliAlert(TM) GPS Tracking a

[ Mon, Oct 24th 2011 ] - Market Wire

Aeolus Pharmaceuticals Announces NIH Counteract G .. 10150 as a Treatment Against Nerve Agent Exposure

[ Mon, Oct 24th 2011 ] - Market Wire

Novadaq to Release Q3-2011 Financial Results on November 4-Conference Call to Follow

[ Mon, Oct 24th 2011 ] - Market Wire

Waters Recognizes the Dr. Ganesh Anand Laboratory .. l University of Singapore as Center of Innovation

Sat, October 22, 2011

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec und Abbott prsentieren positive Daten .. ase-IIb-Studie SELECT auf dem ECTRIMS/ACTRIMS-Kon

[ Sat, Oct 22nd 2011 ] - Market Wire

Zimmer presenta il sistema a vite pedicolare Path .. minimamente invasivo destinato al mercato europeo

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec en Abbott presenteren positieve resul .. P uit Select fase 2b onderzoek op ECTRIMS/ACTRIMS

[ Sat, Oct 22nd 2011 ] - Market Wire

Biogen Idec et Abbott pr©sentent les r©sultats .. phase 2b pour le Daclizumab HYP lors du congrs EC

Fri, October 21, 2011

[ Fri, Oct 21st 2011 ] - Market Wire

Kahn Swick &;; Foti, LLC and Former Lou .. nce Securities Class Action Lawsuit Against K-V P

[ Fri, Oct 21st 2011 ] - Market Wire

Data From Phase 2 Clinical Studies of Telotristat .. rcinoid Syndrome to be Presented at North America

[ Fri, Oct 21st 2011 ] - Market Wire

Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011

[ Fri, Oct 21st 2011 ] - Market Wire

Federman &;; Sherwood Announces That a .. it Has Been Filed Against K-V Pharmaceutical Comp

[ Fri, Oct 21st 2011 ] - Market Wire

AMAG Pharmaceuticals Announces Results of Special Stockholder Meeting Regarding Proposed Merger

[ Fri, Oct 21st 2011 ] - Market Wire

Dynavax and GlaxoSmithKline Expand Their Worldwide Strategic Alliance

[ Fri, Oct 21st 2011 ] - Market Wire

Wall Street Reporter, Inc. Interviews Micro Imagi .. echnology, Inc. Chairman and CEO, Michael Brennan

[ Fri, Oct 21st 2011 ] - Market Wire

AVI BioPharma's RNA-Based Therapeutics for Treatm .. ses Show Positive Safety Data in First Five of Si

[ Fri, Oct 21st 2011 ] - Market Wire

For The Earth Corporation Strengthens Its Portfolio With Kat Box King

[ Fri, Oct 21st 2011 ] - Market Wire

GTx, Inc. To Host Third Quarter 2011 Financial Results Conference Call and Webcast

[ Fri, Oct 21st 2011 ] - Market Wire

Teleflex Signs Definitive Agreement to Sell Aerospace Businesses for $280 Million

[ Fri, Oct 21st 2011 ] - Market Wire

Magellan Health Services to Present at Academy of Managed Care Pharmacy Educational Conference

[ Fri, Oct 21st 2011 ] - Market Wire

Oral BG-12 (Dimetil Fumarato) reduce notablemente .. con esclerosis multiple (MS) y el avance de la d

[ Fri, Oct 21st 2011 ] - Market Wire

Oraal toegediende BG-12 (dimethyl fumaraat) reduc .. lerose en voortschrijding aftakeling in Fase 3 DE

[ Fri, Oct 21st 2011 ] - Market Wire

Acorda Therapeutics Announces Data on AMPYRA® Pr .. h Joint Triennial Congress of ECTRIMS and ACTRIMS

[ Fri, Oct 21st 2011 ] - Market Wire

Reduzierte Schubhufigkeit und Behinderungsprogres .. durch oral verabreichtes BG-12 (Dimethylfumarat):

[ Fri, Oct 21st 2011 ] - Market Wire

Selon les observations de l'essai clinique DEFINE .. -12 (dim©thylfumarate) r©duit de manire signifi

Thu, October 20, 2011

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec und Elan melden Verlngerung der PDUFA-Frist

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec y Elan reciben notificacin de ampliacin de la fecha PDUFA

[ Thu, Oct 20th 2011 ] - Market Wire

Critical Outcome Technologies Inc. Successfully Completes Critical Study

[ Thu, Oct 20th 2011 ] - Market Wire

Analyst View, Impact of Global Events - Research .. on &;; Johnson and Endo Pharmaceuticals

[ Thu, Oct 20th 2011 ] - Market Wire

Dendreon Announces Webcast Presentations at Upcoming Conferences

[ Thu, Oct 20th 2011 ] - Market Wire

Biogen Idec and Elan Receive Notification of PDUFA Date Extension

[ Thu, Oct 20th 2011 ] - Market Wire

Alnylam to Webcast Presentation at the Newsmakers in the Biotech Industry 2011 Conference

[ Thu, Oct 20th 2011 ] - Market Wire

Allon Therapeutics Announces Completion of Patient Enrollment in Pivotal Trial

[ Thu, Oct 20th 2011 ] - Market Wire

POZEN Announces November 3, 2011 Webcast of Third Quarter 2011 Results

[ Thu, Oct 20th 2011 ] - Market Wire

Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial

[ Thu, Oct 20th 2011 ] - Market Wire

Cambridge Heart Announces Initial Results of OEM Module Marketing Promotion

[ Thu, Oct 20th 2011 ] - Market Wire

Manchester Heart Centre in United Kingdom Obtains VMS(TM) Heart Analysis System

[ Thu, Oct 20th 2011 ] - Market Wire

Covidien Releases Clinical Data from Largest Pros .. Plaque Excision for Treatment of Peripheral Arter

[ Thu, Oct 20th 2011 ] - Market Wire

Five Star Quality Care, Inc. Third Quarter Conference Call Scheduled for Thursday, October 27th

[ Thu, Oct 20th 2011 ] - Market Wire

Syneron kndigt weltweite Einfhrung einer neuen Ko .. echnologien fr die Gesichtsbehandlung mit dem eTw

[ Thu, Oct 20th 2011 ] - Market Wire

Device Master File for OncoSec Medical System Completed and Submitted to FDA

[ Thu, Oct 20th 2011 ] - Market Wire

Comprehensive Care Corporation CEO Clark A. Marcus Praised for U.S. Chamber of Commerce Service

Wed, October 19, 2011

[ Wed, Oct 19th 2011 ] - Market Wire

Sun Healthcare Group, Inc. to Release Third-Quarter Results for 2011 and Schedules Conference Call

[ Wed, Oct 19th 2011 ] - Market Wire

CML HealthCare Inc. Declares October Dividend

[ Wed, Oct 19th 2011 ] - Market Wire

Allied Healthcare International Inc. Shareholders Approve Acquisition by Saga Group Limited

[ Wed, Oct 19th 2011 ] - Market Wire

Gegevens over vroeg gebruik en baten op lange ter .. d op 5de gezamenlijk driejaarlijks congres over b

[ Wed, Oct 19th 2011 ] - Market Wire

Des r©sultats relatifs l'utilisation pr©coce et .. YSABRI sont pr©sent©s l'occasion du 5e Congrs t

[ Wed, Oct 19th 2011 ] - Market Wire

Los datos sobre el uso temprano y los beneficios .. sido presentados en el 5 congreso trienal conjun

[ Wed, Oct 19th 2011 ] - Market Wire

Theratechnologies Announces Application for Registration of Tesamorelin in Mexico

[ Wed, Oct 19th 2011 ] - Market Wire

Diligent Board Member Services Ranked Number 156 .. rth America on Deloitte's 2011 Technology Fast 50

[ Wed, Oct 19th 2011 ] - Market Wire

Marina Biotech Demonstrates In Vivo Dose-Dependen .. erability With a CRN-Substituted miRNA Antagonist

[ Wed, Oct 19th 2011 ] - Market Wire

Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting

[ Wed, Oct 19th 2011 ] - Market Wire

UNITEDHEALTHCARE OFRECE AUDFONOS SIN COSTO DE DES .. PARA LOS BENEFICIARIOS DEL CONDADO DE MIAMI-DADE

[ Wed, Oct 19th 2011 ] - Market Wire

Vertex Submits Application for Priority Review an .. 770, ivacaftor) in the U.S. as First Potential Me

[ Wed, Oct 19th 2011 ] - Market Wire

Ligand Enters into Platform Captisol® License Agreement with SAGE Therapeutics

[ Wed, Oct 19th 2011 ] - Market Wire

Single Pharmaceutical-Based Strategy Aims to Solve Neurological and Psychiatric Disorders

[ Wed, Oct 19th 2011 ] - Market Wire

Daten ber Vorteile frhzeitiger bzw. langfristiger .. f 5. dreijhrlichem gemeinsamem Kongress von ECTRI

[ Wed, Oct 19th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at BIO Investor Forum on October 26th

[ Wed, Oct 19th 2011 ] - Market Wire

Presentati al 5o congresso triennale congiunto di .. ivi alla?uso precoce e ai vantaggi a lungo termin

Tue, October 18, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Law Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.

[ Tue, Oct 18th 2011 ] - Market Wire

Vanda Pharmaceuticals to Announce Third Quarter 2011 Financial Results on November 4, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Cytokinetics Announces Strategic Restructuring

[ Tue, Oct 18th 2011 ] - Market Wire

Greatbatch, Inc. to Host Third Quarter 2011 Earnings Conference Call on October 27, 2011

[ Tue, Oct 18th 2011 ] - Market Wire

Aetna Earns J.D. Power and Associates 2011 Call Center Certification

[ Tue, Oct 18th 2011 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. vestment in Stereotaxis, Inc. to Inquire About th

[ Tue, Oct 18th 2011 ] - Market Wire

Exactech Schedules Third Quarter 2011 Earnings Release and Conference Call

[ Tue, Oct 18th 2011 ] - Market Wire

Allon Therapeutics Completes Equity Offering

[ Tue, Oct 18th 2011 ] - Market Wire

Flamel Technologies Announces Multi-Year Supply A .. ith GlaxoSmithKline for Coreg CRa" Microparticles

[ Tue, Oct 18th 2011 ] - Market Wire

MethylGene Receives FDA IND Approval to Begin a P .. ith MGCD290, a Novel Antifungal Product Candidate

[ Tue, Oct 18th 2011 ] - Market Wire

Human Genome Sciences to Sponsor Conference Call to Discuss Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2011 Financial Results

[ Tue, Oct 18th 2011 ] - Market Wire

Given Imaging Announces New Study Shows Impact of .. lCam(R) SB on Management of Symptomatic IBD Cases

[ Tue, Oct 18th 2011 ] - Market Wire

Dr. Roberto Romero, NIH Principal Investigator of .. by Columbia Laboratories, Honored with John Ding

[ Tue, Oct 18th 2011 ] - Market Wire

Reflect Scientific, Inc. Introduces Cryometrix Model B-120 Blast Freezer

[ Tue, Oct 18th 2011 ] - Market Wire

Greystone Logistics Announces Preliminary Financial Results for 1st Quarter

[ Tue, Oct 18th 2011 ] - Market Wire

DaVita Announces Estimate of Third Quarter 2011 Results

Mon, October 17, 2011

[ Mon, Oct 17th 2011 ] - Market Wire

Afexa Announces Take-Up of Shares Under Valeant Offer

[ Mon, Oct 17th 2011 ] - Market Wire

Izard Nobel LLP Announces Class Action Lawsuit Against Stereotaxis, Inc.

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Elects Michael O. Leavitt to the Board of Directors

[ Mon, Oct 17th 2011 ] - Market Wire

Cubist Pharmaceuticals Appoints Jennifer Jackson as Senior Vice President, Regulatory Affairs

[ Mon, Oct 17th 2011 ] - Market Wire

Tripp Levy PLLC Announces Investigation of Anadys Pharmaceuticals

[ Mon, Oct 17th 2011 ] - Market Wire

Futuremed Announces Timing of Third Quarter 2011 Results &;; Conference Call

[ Mon, Oct 17th 2011 ] - Market Wire

Leisureworld Announces October Dividend

[ Mon, Oct 17th 2011 ] - Market Wire

Medtronic Announces 510(k) Clearance for the Aqua .. ined Hemostatic Sealing and Cutting Functionality

[ Mon, Oct 17th 2011 ] - Market Wire

PharmStar Outstanding Common Stock Reduced by 50%

[ Mon, Oct 17th 2011 ] - Market Wire

AdCare Health Systems to Acquire Five Skilled Nursing Facilities in Oklahoma

[ Mon, Oct 17th 2011 ] - Market Wire

Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials

[ Mon, Oct 17th 2011 ] - Market Wire

Marina Biotech, Inc. Announces a $15 Million Purc .. ase Agreement With Lincoln Park Capital Fund, LLC

[ Mon, Oct 17th 2011 ] - Market Wire

DMRJ Amends Implant Sciences' Credit Facility

[ Mon, Oct 17th 2011 ] - Market Wire

Immunovaccine Appoints Wayne Pisano to its Board

[ Mon, Oct 17th 2011 ] - Market Wire

Cellceutix Confident as Cancer Compound Shows Activity in All Cancers Tested

[ Mon, Oct 17th 2011 ] - Market Wire

CytoSorbents Corporation Launches HemoDefend Puri .. for Blood Transfusion Applications at the AABB Co

[ Mon, Oct 17th 2011 ] - Market Wire

Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer

Sun, October 16, 2011

[ Sun, Oct 16th 2011 ] - Market Wire

China Medical Technologies Announces the Approval .. Technology Enterprise Status for a Major Subsidia

Sat, October 15, 2011

[ Sat, Oct 15th 2011 ] - Market Wire

The Medicines Company's MDCO-2010 Meets Clinical .. ectives in Patients Undergoing Open-Heart Surgery

Fri, October 14, 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Newly Published Study Highlights Systemic Growth .. g" Market;; DRM Ventures (DRM) and Patient

[ Fri, Oct 14th 2011 ] - Market Wire

Par Pharmaceutical Files Declaratory Judgment to .. s to Disseminate Truthful Information Regarding M

[ Fri, Oct 14th 2011 ] - Market Wire

Sangamo BioSciences Announces Presentation at the .. ual Newsmakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

MannKind to Present at The 18th Annual Newsmakers in the BioTech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Amarillo Biosciences Issues Corporate Update

[ Fri, Oct 14th 2011 ] - Market Wire

Enzo Reports Record Revenues of $102 Million for Fiscal Year 2011

[ Fri, Oct 14th 2011 ] - Market Wire

Greatbatch, Inc. Elects Anthony P. Bihl III to its Board of Directors

[ Fri, Oct 14th 2011 ] - Market Wire

New Data on Tevaa?s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS

[ Fri, Oct 14th 2011 ] - Market Wire

Dynavax to Present at Newsmakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

MSA Completes Sale of North Carolina Ballistic Vest Business

[ Fri, Oct 14th 2011 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Stereotaxis, Inc.

[ Fri, Oct 14th 2011 ] - Market Wire

Teva Completes Acquisition of Cephalon

[ Fri, Oct 14th 2011 ] - Market Wire

Brookwater Announces Hiring of One of the Largest .. physical &;; Geological Teams in Brazil

[ Fri, Oct 14th 2011 ] - Market Wire

Funding Security Critical to Long Term Success of Biotech Firms

[ Fri, Oct 14th 2011 ] - Market Wire

Skanska Awarded R&D Lab Renovation Contract for USD 80 M, About SEK 512 M

[ Fri, Oct 14th 2011 ] - Market Wire

Columbia Laboratories to Present October 21st at NewsMakers in the Biotech Industry Conference

[ Fri, Oct 14th 2011 ] - Market Wire

Astex Pharmaceuticals to Present at NewsMakers in the Biotech Industry on October 21st

Thu, October 13, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Kindred Healthcare Commences Registered Exchange Offer for Its 8.25% Senior Notes Due 2019

[ Thu, Oct 13th 2011 ] - Market Wire

Trimel Appoints John Friedrichsen to Its Board of Director

[ Thu, Oct 13th 2011 ] - Market Wire

National Imaging Associates Launches Imaging Demo .. ject for Centers for Medicare & Medicaid Services

[ Thu, Oct 13th 2011 ] - Market Wire

Amica Mature Lifestyles to Announce First Quarter .. esults and Host Conference Call November 14, 2011

[ Thu, Oct 13th 2011 ] - Market Wire

Strong Pipelines From Allos Therapeutics and Dynavax Tech Poised to Pay Off

[ Thu, Oct 13th 2011 ] - Market Wire

High Growth Biotech Firms Zalicus and Sequenom Ready for Knockout Fourth Quarter

[ Thu, Oct 13th 2011 ] - Market Wire

Vanguard Health Systems Appoints Former Tennessee Governor to Board of Directors

[ Thu, Oct 13th 2011 ] - Market Wire

AMRI Appoints New President, India Operations and .. of Project Management a" Pharmaceutical Services

[ Thu, Oct 13th 2011 ] - Market Wire

Synageva BioPharma and Trimeris Announce Special Meetings of Stockholders to Approve Merger

[ Thu, Oct 13th 2011 ] - Market Wire

Mercka?s ISENTRESS® (raltegravir) in Combination .. cal and Immunological Efficacy Versus the Efavire

[ Thu, Oct 13th 2011 ] - Market Wire

Micromet Obtains FDA Feedback on Registration Strategy for Blinatumomab in Relapsed/Refractory ALL

[ Thu, Oct 13th 2011 ] - Market Wire

Horizon Pharma Receives U.S. Patent Allowance for DUEXIS(R) in the United States

[ Thu, Oct 13th 2011 ] - Market Wire

U.S. Sales of EGRIFTA(R) Driving Revenue Growth

[ Thu, Oct 13th 2011 ] - Market Wire

Los datos presentados durante el 5 Congreso trien .. or ECTRIMS y ACTRIMS demuestran el compromiso y l

[ Thu, Oct 13th 2011 ] - Market Wire

ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)

[ Thu, Oct 13th 2011 ] - Market Wire

ISTA Pharmaceuticals Reports Results From the Sec .. URA(TM) Phase 3 Clinical Program for Dry Eye Dise

[ Thu, Oct 13th 2011 ] - Market Wire

China Medical Technologies Receives SFDA Approval .. ed KRAS Assay for Colorectal Cancer Targeted Drug

Wed, October 12, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Financial Statement 10/11

[ Wed, Oct 12th 2011 ] - Market Wire

Neue Daten, die auf dem 5. gemeinsamen Kongress v .. tellt werden, zeigen neue Forschungsanstze von Bi

[ Wed, Oct 12th 2011 ] - Market Wire

Savient Pharmaceuticals to Hold Third Quarter 201 .. lts Conference Call on Thursday, November 3, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Cumberland Pharmaceuticals Appoints Rick S. Greene Chief Financial Officer

[ Wed, Oct 12th 2011 ] - Market Wire

Helix BioPharma Corp. Files IND Clinical Hold Res .. d Topical Interferon Alpha-2b Phase II/III Effica

[ Wed, Oct 12th 2011 ] - Market Wire

Mylan Announces Intention to Refinance Existing Secured Credit Facility

[ Wed, Oct 12th 2011 ] - Market Wire

Ion Torrent Gets Better Faster With 4th Qtr New Product Releases

[ Wed, Oct 12th 2011 ] - Market Wire

Tornier Announces Conference Call of Third Quarter Results

[ Wed, Oct 12th 2011 ] - Market Wire

The Medicines Company to Announce Third Quarter 2 .. Financial Results on Wednesday, October 26, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Assisted Living Concepts, Inc. Schedules Third Quarter Financial Results Conference Call

[ Wed, Oct 12th 2011 ] - Market Wire

Dynavax to Host Analyst &;; Investor Day Webcast October 27, 2011

[ Wed, Oct 12th 2011 ] - Market Wire

Gegevens gepresenteerd op het vijfde gezamenlijke .. CTRIMS en ACTRIMS tonen de innovatieve wetenschap

[ Wed, Oct 12th 2011 ] - Market Wire

Micro Imaging Technology Announces a Date for Its Annual General Shareholders Meeting

Unigene to Present at the 10th Annual BIO Investor Forum on October 25, 2011

_{//health-fitness.news-articles.net/content/2011/ .. nnual-bio-investor-forum-on-october-25-2011.html}
^{Published in Health and Fitness on Thursday, October 20th 2011 at 5:49 GMT by Market Wire}

BOONTON, N.J.--([ BUSINESS WIRE ])--Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that Ashleigh Palmer, President and Chief Executive Officer will be presenting a corporate overview at the 10th Annual BIO Investor Forum being held in San Francisco, CA. Mr. Palmera�s live presentation is scheduled to begin at 10:00 a.m. Pacific Time on Tuesday, October 25, 2011.

Individuals can listen to a live webcast of the presentation by logging on to the Investors and Media section under the Events tab of the Unigene web site, [ http://www.unigene.com ]. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the Company's web site for 30 days.

About Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a leader in the design, delivery, manufacture and development of peptide-based therapeutics. The Company is building a robust portfolio of proprietary partnerships in this expanding drug class based on its Peptelligencea" platform. Peptelligence encompasses extensive intellectual property covering delivery and manufacturing technologies, unsurpassed research and development expertise, and proprietary know-how representing a genuine distinctive competence. Core Peptelligence assets include proprietary oral and nasal peptide delivery technologies, and proprietary, high-yield, scalable and reproducible E. coli-based manufacturing technologies.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire